PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.48%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
56.29%
Positive gross profit growth while AR is negative. John Neff would see a clear operational edge over the competitor.
100.00%
Positive EBIT growth while AR is negative. John Neff might see a substantial edge in operational management.
674.16%
Positive operating income growth while AR is negative. John Neff might view this as a competitive edge in operations.
293.08%
Positive net income growth while AR is negative. John Neff might see a big relative performance advantage.
295.08%
Positive EPS growth while AR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
293.44%
Positive diluted EPS growth while AR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.54%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.12%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.75%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-100.00%
Negative OCF growth while AR is at 7.56%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-303.52%
Negative FCF growth while AR is at 15.38%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
81.41%
10Y revenue/share CAGR under 50% of AR's 226.56%. Michael Burry would suspect a lasting competitive disadvantage.
220.27%
5Y revenue/share CAGR above 1.5x AR's 76.73%. David Dodd would look for consistent product or market expansions fueling outperformance.
-38.39%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-100.00%
Negative 10Y OCF/share CAGR while AR stands at 83.73%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while AR is at 266.41%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
112.39%
Net income/share CAGR at 50-75% of AR's 196.15%. Martin Whitman might question if the firm’s product or cost base lags behind.
107.03%
5Y net income/share CAGR at 75-90% of AR's 129.17%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
-77.53%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-13.77%
Negative equity/share CAGR over 10 years while AR stands at 24.95%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
77.24%
5Y equity/share CAGR above 1.5x AR's 2.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
77.03%
3Y equity/share CAGR above 1.5x AR's 31.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
35.18%
10Y dividend/share CAGR above 1.5x AR's 12.12%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
208.95%
Dividend/share CAGR of 208.95% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
19.48%
3Y dividend/share CAGR of 19.48% while AR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
272.06%
Positive asset growth while AR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.50%
BV/share growth above 1.5x AR's 1.35%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.50%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while AR invests at 24.05%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.